351 related articles for article (PubMed ID: 26391856)
1. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
Iima M; Le Bihan D; Okumura R; Okada T; Fujimoto K; Kanao S; Tanaka S; Fujimoto M; Sakashita H; Togashi K
Radiology; 2011 Aug; 260(2):364-72. PubMed ID: 21633054
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
[TBL] [Abstract][Full Text] [Related]
4. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
5. Histogram analysis of volume-based apparent diffusion coefficient in breast cancer.
Park GE; Kim SH; Kim EJ; Kang BJ; Park MS
Acta Radiol; 2017 Nov; 58(11):1294-1302. PubMed ID: 28273747
[TBL] [Abstract][Full Text] [Related]
6. Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.
Mori N; Ota H; Mugikura S; Takasawa C; Tominaga J; Ishida T; Watanabe M; Takase K; Takahashi S
Eur Radiol; 2013 Oct; 23(10):2705-12. PubMed ID: 23732688
[TBL] [Abstract][Full Text] [Related]
7. Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ.
Bickel H; Pinker-Domenig K; Bogner W; Spick C; Bagó-Horváth Z; Weber M; Helbich T; Baltzer P
Invest Radiol; 2015 Feb; 50(2):95-100. PubMed ID: 25333308
[TBL] [Abstract][Full Text] [Related]
8. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
9. [Values of Minimal Apparent Diffusion Coefficient,Difference between Ratios of Apparent Diffusion Coefficients,and Dynamic Contrast-enhanced Magnetic Resonance Imaging Features in Diagnosing Breast Ductal Carcinoma In Situ with Microinvasion].
Wu P; Cui L; Guo BH; Wang YC; Cui JS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):737-745. PubMed ID: 31907122
[No Abstract] [Full Text] [Related]
10. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma
Zhao S; Shao G; Chen P; Li L; Yang Y; Zhao X; Guo W
J Cancer Res Ther; 2019; 15(4):871-875. PubMed ID: 31436245
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ.
Yoon HJ; Kim Y; Kim BS
Eur Radiol; 2015 Dec; 25(12):3648-58. PubMed ID: 26063655
[TBL] [Abstract][Full Text] [Related]
13. Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?
Rizzo V; Cicciarelli F; Galati F; Moffa G; Maroncelli R; Pasculli M; Pediconi F
Acta Radiol; 2024 Jun; 65(6):565-574. PubMed ID: 38196268
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI.
Rahbar H; Partridge SC; Eby PR; Demartini WB; Gutierrez RL; Peacock S; Lehman CD
Eur Radiol; 2011 Sep; 21(9):2011-9. PubMed ID: 21562806
[TBL] [Abstract][Full Text] [Related]
15. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
Rahbar H; Partridge SC; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
Radiology; 2012 May; 263(2):374-82. PubMed ID: 22517955
[TBL] [Abstract][Full Text] [Related]
16. Association of DW/DCE-MRI features with prognostic factors in breast cancer.
Shao G; Fan L; Zhang J; Dai G; Xie T
Int J Biol Markers; 2017 Mar; 32(1):e118-e125. PubMed ID: 27646773
[TBL] [Abstract][Full Text] [Related]
17. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
[TBL] [Abstract][Full Text] [Related]
18. Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.
Chou SS; Gombos EC; Chikarmane SA; Giess CS; Jayender J
J Magn Reson Imaging; 2017 Dec; 46(6):1748-1759. PubMed ID: 28371110
[TBL] [Abstract][Full Text] [Related]
19. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
Miceli R; Gao Y; Qian K; Heller SL
AJR Am J Roentgenol; 2023 Jul; 221(1):34-43. PubMed ID: 36752370
[No Abstract] [Full Text] [Related]
20. Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?
Aydin H; Guner B; Esen Bostanci I; Bulut ZM; Aribas BK; Dogan L; Gulcelik MA
Br J Radiol; 2018 Apr; 91(1084):20170705. PubMed ID: 29299933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]